Interpace Biosciences Inc (IDXG)
1.48
+0.06
(+4.04%)
USD |
OTCM |
Apr 26, 10:34
Interpace Biosciences Net Income (TTM): -0.148M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.148M |
| June 30, 2023 | -15.25M |
| March 31, 2023 | -19.36M |
| December 31, 2022 | -21.96M |
| September 30, 2022 | -24.12M |
| June 30, 2022 | -13.48M |
| March 31, 2022 | -12.98M |
| December 31, 2021 | -14.94M |
| September 30, 2021 | -19.36M |
| June 30, 2021 | -22.03M |
| March 31, 2021 | -24.16M |
| December 31, 2020 | -26.45M |
| September 30, 2020 | -28.97M |
| June 30, 2020 | -30.18M |
| March 31, 2020 | -29.91M |
| December 31, 2019 | -26.74M |
| September 30, 2019 | -20.63M |
| June 30, 2019 | -16.22M |
| March 31, 2019 | -12.84M |
| December 31, 2018 | -12.70M |
| September 30, 2018 | -13.16M |
| June 30, 2018 | -13.43M |
| March 31, 2018 | -17.82M |
| December 31, 2017 | -12.22M |
| September 30, 2017 | -0.927M |
| Date | Value |
|---|---|
| June 30, 2017 | -5.104M |
| March 31, 2017 | -1.132M |
| December 31, 2016 | -8.332M |
| September 30, 2016 | -10.23M |
| June 30, 2016 | -7.63M |
| March 31, 2016 | -12.27M |
| December 31, 2015 | -11.36M |
| September 30, 2015 | -23.21M |
| June 30, 2015 | -22.65M |
| March 31, 2015 | -18.33M |
| December 31, 2014 | -16.07M |
| September 30, 2014 | -12.27M |
| June 30, 2014 | -10.08M |
| March 31, 2014 | -8.302M |
| December 31, 2013 | -4.564M |
| September 30, 2013 | -24.69M |
| June 30, 2013 | -23.57M |
| March 31, 2013 | -23.13M |
| December 31, 2012 | -25.53M |
| September 30, 2012 | -12.00M |
| June 30, 2012 | -11.18M |
| March 31, 2012 | -11.64M |
| December 31, 2011 | -11.91M |
| September 30, 2011 | -4.198M |
| June 30, 2011 | -5.67M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-30.18M
Minimum
Jun 2020
-0.148M
Maximum
Dec 2023
-20.38M
Average
-21.29M
Median
Net Income (TTM) Benchmarks
| Fonar Corp | 12.96M |
| XWELL Inc | -27.74M |
| ProPhase Labs Inc | -16.78M |
| Applied DNA Sciences Inc | -7.209M |
| Veracyte Inc | -74.40M |